Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 11,73100Cr 7.24TCr 6.33TCr 5.84TCr 5.37TCr 10TCr 6,96300Cr 10TCr 70TCr 27TCr 3,40400Cr 27TCr 27TCr P/E 2026 *
23.1x
P/E 2027 * 19.8x
Enterprise Value 10,80900Cr 6.67TCr 5.83TCr 5.38TCr 4.94TCr 9.37TCr 6,41600Cr 9.53TCr 64TCr 25TCr 3,13600Cr 25TCr 24TCr EV / Sales 2026 *
7.8x
EV / Sales 2027 * 6.89x
Free-Float
38.12%
Yield 2026 *
1.92%
Yield 2027 * 2.2%
1 day+2.24%
1 week-0.96%
Current month-3.27%
1 month-3.12%
3 months-15.17%
6 months-11.68%
Current year-11.59%
1 week 7,105
Extreme 7105
7,420
1 month 7,105
Extreme 7105
7,939
Current year 7,105
Extreme 7105
10,700
1 year 5,942
Extreme 5942
10,700
3 years 3,871
Extreme 3871
10,700
5 years 3,191
Extreme 3191
10,700
10 years 1,003.33
Extreme 1003.3333
10,700
Manager TitleAgeSince
Chief Executive Officer 63 01/03/2021
Director of Finance/CFO 59 28/03/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 01/03/2020
Director/Board Member 59 28/03/2024
Director/Board Member 51 01/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
+2.36%-0.96%+7.18%+86.49% 7.36TCr
+0.35%-4.87%+49.87%+157.34% 1,02800Cr
-2.69%-6.22%+59.19%+54.51% 61TCr
+0.44%-3.41%+30.97%+79.48% 43TCr
+0.98%-1.40%+29.49%+21.76% 32TCr
-0.34%-3.10%+27.00%+43.60% 28TCr
+1.63%-11.76%+19.72%+21.72% 26TCr
+3.39%+2.29%-23.68%-37.83% 22TCr
+0.86%-2.63%+22.50%+57.55% 19TCr
+1.28%-3.03%+20.76%+70.62% 16TCr
Average +0.81%-4.64%+24.30%+55.52% 35.72TCr
Weighted average by Cap. +0.23%-4.85%+35.27%+76.90%

Financials

2026 *2027 *
Net sales 1,38600Cr 855.2Cr 747.7Cr 689.74Cr 634.04Cr 1.2TCr 82TCr 1.22TCr 8.23TCr 3.23TCr 40TCr 3.21TCr 3.14TCr 1,53400Cr 946.03Cr 827.11Cr 763Cr 701.39Cr 1.33TCr 91TCr 1.35TCr 9.11TCr 3.57TCr 44TCr 3.55TCr 3.47TCr
Net income 51TCr 313.66Cr 274.23Cr 252.97Cr 232.54Cr 440.62Cr 30TCr 448.15Cr 3.02TCr 1.18TCr 15TCr 1.18TCr 1.15TCr 59TCr 365.36Cr 319.44Cr 294.68Cr 270.88Cr 513.26Cr 35TCr 522.03Cr 3.52TCr 1.38TCr 17TCr 1.37TCr 1.34TCr
Net Debt -92TCr -568.53Cr -497.06Cr -458.53Cr -421.51Cr -798.65Cr -55TCr -812.31Cr -5.47TCr -2.15TCr -27TCr -2.14TCr -2.09TCr -1,16300Cr -717.39Cr -627.22Cr -578.6Cr -531.87Cr -1.01TCr -69TCr -1.03TCr -6.91TCr -2.71TCr -34TCr -2.69TCr -2.64TCr
Logo Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Employees
5,104
Date Price Change Volume
16/26/16 JP¥7,277.00 +2.09% 11,31,900
15/26/15 JP¥7,128.00 -1.56% 23,30,400
14/26/14 JP¥7,241.00 +0.15% 19,73,600
13/26/13 JP¥7,230.00 -2.15% 20,54,100
10/26/10 JP¥7,389.00 +0.41% 26,63,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,128.00JPY
Average target price
9,853.33JPY
Spread / Average Target
+38.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4519 Stock